Digital Health Tools for Diabetes Management and Virtual Musculoskeletal Care to Undergo Independent Evaluation

The Peterson Health Technology Institute (PHTI) has announced that its initial assessments will focus on remote patient monitoring (RPM) for diabetes management and virtual musculoskeletal care. These assessments aim to inform payers, providers, and patients about the clinical and economic impact of these technologies. Due to the lack of clinical evidence in many digital health products, PHTI plans to evaluate several other high-impact clinical areas in 2024. The institute will use a custom assessment framework, released last month, to evaluate technology's clinical benefits, economic impact, and effects on health equity, privacy, and security. The goal is to identify promising aspects of digital health innovation and accelerate the adoption of high-value technology in healthcare. PHTI's assessments will be conducted independently, with stakeholder engagement guiding the selection and assessment process, including input from a Purchaser Advisory Council, clinical experts, provider groups, and patient representatives. The first assessments will focus on diabetes remote patient monitoring and virtual care for musculoskeletal disorders, with future areas of interest to be considered in 2024.